ANN ARBOR, Mich., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces a conference call to be hosted by Kim Thompson and Jon Rice to be held on Friday, December 4, 2015 at 4:30 PM EST. The Company invites all shareholders and other interested parties to participate in the call.
Thompson, the Company’s CEO and Founder and Rice, the Company’s COO, will update shareholders on production, scientific milestones, commercialization strategy and corporate developments. Following the Company progress update, Thompson and Rice will hold a question and answer session moderated by Ben Hansel. Shareholders are invited to submit questions to IR@kraiglabs.com in advance of the call.
The conference call phone number and other details will be announced in a follow-up Company release the week of November 30, 2015.
The Company anticipates posting a recording of the conference call on the Company website shortly after the call for interested parties who are unable to attend the call.
Conference call: 4:30 p.m. EST (Eastern Standard Time), Friday, December 4, 2015.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc